These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24306456)

  • 1. A mild removal of Fmoc group using sodium azide.
    Chen CC; Rajagopal B; Liu XY; Chen KL; Tyan YC; Lin F; Lin PC
    Amino Acids; 2014 Feb; 46(2):367-74. PubMed ID: 24306456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis using Dmab group to protect side chain of aspartic acid.
    Ruczyński J; Lewandowska B; Mucha P; Rekowski P
    J Pept Sci; 2008 Mar; 14(3):335-41. PubMed ID: 17975850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide thioester preparation by Fmoc solid phase peptide synthesis for use in native chemical ligation.
    Clippingdale AB; Barrow CJ; Wade JD
    J Pept Sci; 2000 May; 6(5):225-34. PubMed ID: 10823491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing aspartimide formation in Fmoc SPPS of Asp-Gly containing peptides--practical aspects of new trialkylcarbinol based protecting groups.
    Behrendt R; Huber S; White P
    J Pept Sci; 2016 Feb; 22(2):92-7. PubMed ID: 26751703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry.
    Fields CG; VanDrisse VL; Fields GB
    Pept Res; 1993; 6(1):39-47. PubMed ID: 8439735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic procedure for N-Fmoc amino acyl-N-sulfanylethylaniline linker as crypto-peptide thioester precursor with application to native chemical ligation.
    Sakamoto K; Sato K; Shigenaga A; Tsuji K; Tsuda S; Hibino H; Nishiuchi Y; Otaka A
    J Org Chem; 2012 Aug; 77(16):6948-58. PubMed ID: 22816612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aspartimide problem in Fmoc-based SPPS. Part III.
    Mergler M; Dick F
    J Pept Sci; 2005 Oct; 11(10):650-7. PubMed ID: 15849777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS.
    Behrendt R; Huber S; Martí R; White P
    J Pept Sci; 2015 Aug; 21(8):680-7. PubMed ID: 26077723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.
    Gross CM; Lelièvre D; Woodward CK; Barany G
    J Pept Res; 2005 Mar; 65(3):395-410. PubMed ID: 15787970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Fmoc solid-phase peptide synthesis.
    Behrendt R; White P; Offer J
    J Pept Sci; 2016 Jan; 22(1):4-27. PubMed ID: 26785684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis.
    Palasek SA; Cox ZJ; Collins JM
    J Pept Sci; 2007 Mar; 13(3):143-8. PubMed ID: 17121420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handles for Fmoc solid-phase synthesis of protected peptides.
    Góngora-Benítez M; Tulla-Puche J; Albericio F
    ACS Comb Sci; 2013 May; 15(5):217-28. PubMed ID: 23573835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(N-Fmoc)-3-(N-Boc-N-methoxy)-diaminopropanoic acid, an amino acid for the synthesis of mimics of O-linked glycopeptides.
    Carrasco MR; Brown RT; Doan VH; Kandel SM; Lee FC
    Biopolymers; 2006; 84(4):414-20. PubMed ID: 16508952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
    Luna OF; Gomez J; Cárdenas C; Albericio F; Marshall SH; Guzmán F
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27854291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids.
    Busnel O; Bi L; Dali H; Cheguillaume A; Chevance S; Bondon A; Muller S; Baudy-Floc'h M
    J Org Chem; 2005 Dec; 70(26):10701-8. PubMed ID: 16355988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of C-terminal peptide thioesters using Fmoc-based solid-phase peptide chemistry.
    Shelton PT; Jensen KJ
    Methods Mol Biol; 2013; 1047():119-29. PubMed ID: 23943482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aspartimide problem in Fmoc-based SPPS. Part I.
    Mergler M; Dick F; Sax B; Weiler P; Vorherr T
    J Pept Sci; 2003 Jan; 9(1):36-46. PubMed ID: 12587881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydropyranyl, a nonaromatic acid-labile Cys protecting group for Fmoc peptide chemistry.
    Ramos-Tomillero I; Rodríguez H; Albericio F
    Org Lett; 2015 Apr; 17(7):1680-3. PubMed ID: 25764355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of glyoxylyl peptides using an Fmoc-protected alpha,alpha'-diaminoacetic acid derivative.
    Far S; Melnyk O
    J Pept Sci; 2005 Jul; 11(7):424-30. PubMed ID: 15641117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of in situ silylation for improved, convenient preparation of fluorenylmethoxycarbonyl (Fmoc)-protected phosphinate amino acids.
    Li S; Whitehead JK; Hammer RP
    J Org Chem; 2007 Apr; 72(8):3116-8. PubMed ID: 17375960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.